一例罕见的肝移植受者在非药物治疗的情况下通过改变生活方式缓解 2 型糖尿病的病例:病例报告

Q4 Medicine
Pramod Tripathi , Nidhi Kadam , Baby Sharma , Maheshkumar Kuppusamy , Venugopal Vijayakumar
{"title":"一例罕见的肝移植受者在非药物治疗的情况下通过改变生活方式缓解 2 型糖尿病的病例:病例报告","authors":"Pramod Tripathi ,&nbsp;Nidhi Kadam ,&nbsp;Baby Sharma ,&nbsp;Maheshkumar Kuppusamy ,&nbsp;Venugopal Vijayakumar","doi":"10.1016/j.jecr.2024.100169","DOIUrl":null,"url":null,"abstract":"<div><p>Solid organ transplantation, especially liver transplantation, is higher in patients with Type 2 Diabetes (T2D), with further worsening of glycemic control post-transplantation. This vicious cycle increases the risk of cardiovascular mortality, emphasizing the need for an effective T2D management strategy. We present a unique case of T2D remission through intensive lifestyle modification in a liver transplant recipient. A 55-year-old male liver transplant recipient with a history of T2D since 1995 and insulin therapy for 17 years experienced severe non-alcoholic fatty liver disease (NAFLD) and liver cirrhosis, necessitating a liver transplant in 2016. Post-transplant, he was on insulin and immuno-suppressants. In 2021, the patient joined our one-year diabetes management program, involving intense lifestyle modifications, including a plant-based, low-carbohydrate diet, physical activity, stress management, mindfulness meditation, and medical management. Insulin dose adjustments were made based on daily glucose monitoring. After three months, the patient experienced hypoglycemia, and insulin was discontinued. T2D remission was confirmed by normal blood glucose levels, and HbA1c of 6.3 %, and clearing of oral glucose tolerance tests (OGTT) twice post remission (at 9 and 21 months). This case report provides the first-ever documented evidence of T2D remission through non-pharmacological intervention after liver transplantation. Additionally, it reports the first-ever OGTT clearance following T2D remission post-liver transplantation.</p></div>","PeriodicalId":56186,"journal":{"name":"Journal of Clinical and Translational Endocrinology: Case Reports","volume":"32 ","pages":"Article 100169"},"PeriodicalIF":0.0000,"publicationDate":"2024-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S221462452400008X/pdfft?md5=ec3e357bd6aa2aa1584eec8fadcbaa26&pid=1-s2.0-S221462452400008X-main.pdf","citationCount":"0","resultStr":"{\"title\":\"A rare case of type 2 diabetes remission following non-pharmacological intense lifestyle modification in a liver transplantation recipient: A case report\",\"authors\":\"Pramod Tripathi ,&nbsp;Nidhi Kadam ,&nbsp;Baby Sharma ,&nbsp;Maheshkumar Kuppusamy ,&nbsp;Venugopal Vijayakumar\",\"doi\":\"10.1016/j.jecr.2024.100169\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Solid organ transplantation, especially liver transplantation, is higher in patients with Type 2 Diabetes (T2D), with further worsening of glycemic control post-transplantation. This vicious cycle increases the risk of cardiovascular mortality, emphasizing the need for an effective T2D management strategy. We present a unique case of T2D remission through intensive lifestyle modification in a liver transplant recipient. A 55-year-old male liver transplant recipient with a history of T2D since 1995 and insulin therapy for 17 years experienced severe non-alcoholic fatty liver disease (NAFLD) and liver cirrhosis, necessitating a liver transplant in 2016. Post-transplant, he was on insulin and immuno-suppressants. In 2021, the patient joined our one-year diabetes management program, involving intense lifestyle modifications, including a plant-based, low-carbohydrate diet, physical activity, stress management, mindfulness meditation, and medical management. Insulin dose adjustments were made based on daily glucose monitoring. After three months, the patient experienced hypoglycemia, and insulin was discontinued. T2D remission was confirmed by normal blood glucose levels, and HbA1c of 6.3 %, and clearing of oral glucose tolerance tests (OGTT) twice post remission (at 9 and 21 months). This case report provides the first-ever documented evidence of T2D remission through non-pharmacological intervention after liver transplantation. Additionally, it reports the first-ever OGTT clearance following T2D remission post-liver transplantation.</p></div>\",\"PeriodicalId\":56186,\"journal\":{\"name\":\"Journal of Clinical and Translational Endocrinology: Case Reports\",\"volume\":\"32 \",\"pages\":\"Article 100169\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-04-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S221462452400008X/pdfft?md5=ec3e357bd6aa2aa1584eec8fadcbaa26&pid=1-s2.0-S221462452400008X-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Clinical and Translational Endocrinology: Case Reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S221462452400008X\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical and Translational Endocrinology: Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S221462452400008X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

2型糖尿病(T2D)患者接受实体器官移植(尤其是肝移植)的比例较高,移植后血糖控制进一步恶化。这种恶性循环增加了心血管死亡的风险,因此需要采取有效的 T2D 管理策略。我们介绍了一例肝移植受者通过强化生活方式调整缓解 T2D 的独特病例。一位 55 岁的男性肝移植受者自 1995 年起就患有 T2D,并接受了 17 年的胰岛素治疗,后来出现了严重的非酒精性脂肪肝(NAFLD)和肝硬化,不得不在 2016 年进行了肝移植。移植后,他一直在使用胰岛素和免疫抑制剂。2021 年,患者参加了我们为期一年的糖尿病管理计划,其中包括严格的生活方式调整,包括以植物为基础的低碳水化合物饮食、体育锻炼、压力管理、正念冥想和医疗管理。我们根据每日血糖监测结果调整胰岛素剂量。三个月后,患者出现低血糖,胰岛素被停用。血糖水平正常,HbA1c 为 6.3%,缓解后两次(9 个月和 21 个月)口服葡萄糖耐量试验(OGTT)均无异常,这证实了 T2D 的缓解。本病例报告首次提供了肝移植后通过非药物干预缓解 T2D 的记录证据。此外,它还首次报告了肝移植后 T2D 缓解后的 OGTT 清除情况。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
A rare case of type 2 diabetes remission following non-pharmacological intense lifestyle modification in a liver transplantation recipient: A case report

Solid organ transplantation, especially liver transplantation, is higher in patients with Type 2 Diabetes (T2D), with further worsening of glycemic control post-transplantation. This vicious cycle increases the risk of cardiovascular mortality, emphasizing the need for an effective T2D management strategy. We present a unique case of T2D remission through intensive lifestyle modification in a liver transplant recipient. A 55-year-old male liver transplant recipient with a history of T2D since 1995 and insulin therapy for 17 years experienced severe non-alcoholic fatty liver disease (NAFLD) and liver cirrhosis, necessitating a liver transplant in 2016. Post-transplant, he was on insulin and immuno-suppressants. In 2021, the patient joined our one-year diabetes management program, involving intense lifestyle modifications, including a plant-based, low-carbohydrate diet, physical activity, stress management, mindfulness meditation, and medical management. Insulin dose adjustments were made based on daily glucose monitoring. After three months, the patient experienced hypoglycemia, and insulin was discontinued. T2D remission was confirmed by normal blood glucose levels, and HbA1c of 6.3 %, and clearing of oral glucose tolerance tests (OGTT) twice post remission (at 9 and 21 months). This case report provides the first-ever documented evidence of T2D remission through non-pharmacological intervention after liver transplantation. Additionally, it reports the first-ever OGTT clearance following T2D remission post-liver transplantation.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Clinical and Translational Endocrinology: Case Reports
Journal of Clinical and Translational Endocrinology: Case Reports Medicine-Endocrinology, Diabetes and Metabolism
CiteScore
1.10
自引率
0.00%
发文量
32
审稿时长
27 weeks
期刊介绍: The journal publishes case reports in a variety of disciplines in endocrinology, including diabetes, metabolic bone disease and osteoporosis, thyroid disease, pituitary and lipid disorders. Journal of Clinical & Translational Endocrinology Case Reports is an open access publication.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信